Symposia
Technology/Digital Health
Joanna Arch, Ph.D. (she/her/hers)
Professor
University of Colorado Boulder
Boulder, CO, United States
Joanna Arch, Ph.D. (she/her/hers)
Professor
University of Colorado Boulder
Boulder, CO, United States
Jill Mitchell, PhD, MSW, LCSW
Clinical Social Worker, Director of Psycho-Oncology Research
Rocky Mountain Cancer Centers
Boulder, CO, United States
Sarah Genung, BA
Study Coordinator
University of Colorado Boulder
Boulder, CO, United States
Madeline Nealis, MPH
Study Coordinator
University of Colorado Boulder
Boulder, CO, United States
Sarah Schmiege, PhD (she/her/hers)
Biostatistician
Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus
Aurora, CO, United States
Michael E. Levin, Ph.D.
Professor
Utah State University
Salt Lake City, UT, United States
David Andorsky, MD
Medical Oncologist
Rocky Mountain Cancer Centers
Boulder, CO, United States
Regina Fink, PhD (she/her/hers)
Professor Emeritus
Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine
Aurora, CO, United States
Jean Kutner, MD, MPH/MSPH
Professor of Medicine
University of Colorado Anschutz School of Medicine
Aurora, CO, United States
Background: Due to advances in medical treatment, an increasing number of people are living longer with advanced, likely incurable cancer. High levels of anxiety, depression, and fear of dying are common among them. Also, planning for future healthcare decisions, known as advance care planning, remains a challenge. This study tests a novel, multi-modal acceptance and commitment therapy (M-ACT) group intervention delivered online in community clinics to increase psychological well-being and advance care planning among anxious and depressed adults with advanced cancer. By focusing on delivery by community providers to community patients, this study embodies the conference theme of “Bridging the Divide.”
Methods: Adults with advanced cancer and elevated anxiety or depression symptoms (N=249) were randomized 1:1 within cohorts to the innovative M-ACT intervention consisting of 5 weekly online videoconference ACT groups led by clinical social workers in community cancer care clinics plus online, self-paced ACT sessions, or usual care (UC). The primary outcome was total number of advance care planning steps reported as completed or updated by 2-month follow-up. Secondary outcomes included depression, anxiety, fear of death/dying, sense of life meaning, and broader advance care planning engagement.
Results: From baseline to 2-month follow-up, M-ACT led to significantly more advance care planning steps than UC (p< .01). In longitudinal modeling of group differences over time, M-ACT also led to more improvement in depression (p< .05), fear of dying (p< .05), spiritual well-being (p< .05), and broader advance care planning engagement (p< .01) than UC. Conditions did not differ on anxiety outcomes.
Conclusion: This large randomized trial provides strong support for the efficacy of the brief, online M-ACT intervention for improving psychological and spiritual well-being and advance care planning among anxious and depressed adults with advanced cancer. By embedding this trial in community clinics, this work yields findings that are relevant to the community settings where most US cancer survivors receive care.